| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |